Arbutus Biopharma Corpora... (ABUS)
NASDAQ: ABUS
· Real-Time Price · USD
3.33
-0.04 (-1.19%)
At close: Aug 15, 2025, 3:59 PM
3.37
1.01%
After-hours: Aug 15, 2025, 05:47 PM EDT
Arbutus Biopharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 10.74M | 1.76M | 1.57M | 1.34M | 1.73M | 1.53M | 2.15M | 4.66M | 4.65M | 6.69M | 6.25M | 5.95M | 14.24M | 12.58M | 3.21M | 3.34M | 2.33M | 2.11M |
Cost of Revenue | 11K | 8.96M | 333K | n/a | 356K | 15.4M | 359K | 369K | 342K | 334K | 307K | 343K | 383K | 394K | 427K | 16.71M | 15.8M | 13.78M |
Gross Profit | 10.73M | -7.2M | 1.24M | 1.34M | 1.37M | 1.18M | 1.79M | 4.29M | 4.31M | 6.35M | 5.94M | 5.61M | 13.86M | 12.19M | 2.78M | -13.37M | -13.47M | -11.67M |
Operating Income | 1.91M | -34.66M | -13.93M | -21.44M | -21.37M | -19.18M | -20.52M | -21.56M | -18.39M | -17.41M | -22.56M | -17.81M | -14.11M | -10.97M | -20.8M | -18.41M | -18.64M | -15.68M |
Interest Income | 1.04M | 1.2M | 1.46M | 1.75M | 1.83M | 1.54M | 1.47M | 1.49M | 1.46M | 1.27M | 943K | 694K | 396K | 159K | 30K | 27K | 31K | 39K |
Pretax Income | 2.52M | -24.53M | -12.53M | -19.72M | -19.8M | -17.88M | -19.31M | -20.1M | -17.09M | -16.34M | -21.93M | -17.57M | -14.19M | -11.32M | -21.32M | -19.16M | -19.39M | -16.38M |
Net Income | 2.52M | -24.53M | -12.53M | -19.72M | -19.8M | -17.88M | -19.31M | -20.1M | -17.09M | -15.46M | -22.91M | -17.32M | -14.28M | -15.77M | -21.32M | -19.16M | -19.39M | -16.38M |
Selling & General & Admin | 3.32M | 5.83M | 4.71M | 4.54M | 7.19M | 4.96M | 4.74M | 5.84M | 5.98M | 5.55M | 4.25M | 3.49M | 5.2M | 4.89M | 4.7M | 4.15M | 4.45M | 3.85M |
Research & Development | 5.5M | 8.96M | 8.81M | 14.27M | 15.55M | 15.4M | 17.56M | 20.17M | 17.69M | 18.27M | 22.95M | 20.05M | 22.94M | 18.46M | 20.44M | 16.3M | 15.4M | 13.37M |
Other Expenses | n/a | 12.67M | 1.99M | 3.97M | 211K | 180K | n/a | 205K | n/a | 273K | 2.02M | 215K | 208K | 201K | -1.33M | 447K | 436K | 443K |
Operating Expenses | 8.81M | 27.46M | 15.51M | 22.78M | 22.74M | 20.36M | 22.31M | 26.22M | 23.67M | 23.83M | 27.2M | 23.55M | 28.14M | 23.35M | 23.81M | 20.89M | 20.28M | 17.66M |
Interest Expense | 28K | 28K | 30K | 29K | 34K | 44K | 44K | 46K | 171K | 198K | 309K | 429K | 482K | 506K | 560K | 762K | 763K | 772K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -356K | -355K | -359K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 8.83M | 36.42M | 15.51M | 22.78M | 23.1M | 20.71M | 22.66M | 26.22M | 23.67M | 23.83M | 27.2M | 23.55M | 28.14M | 23.35M | 23.81M | 20.89M | 20.28M | 17.66M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | 1.07M | n/a | 171K | -876K | 979K | -244K | 83K | 4.44M | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 191.55M | 190.71M | 185.61M | 189M | 188.04M | 175.63M | 168.44M | 167.51M | 166.06M | 161.64M | 154.42M | 151M | 148.75M | 143.32M | 101.29M | 101.02M | 96.87M | 93.43M |
Shares Outstanding (Diluted) | 192.4M | 190.71M | 189.96M | 189M | 188.04M | 175.63M | 168.44M | 167.51M | 166.06M | 161.64M | 154.42M | 151M | 148.75M | 148.43M | 101.29M | 101.29M | 96.87M | 93.43M |
EPS (Basic) | 0.01 | -0.13 | -0.07 | -0.1 | -0.11 | -0.1 | -0.11 | -0.12 | -0.1 | -0.1 | -0.15 | -0.11 | -0.1 | -0.11 | -0.21 | -0.19 | -0.2 | -0.18 |
EPS (Diluted) | 0.01 | -0.13 | -0.07 | -0.1 | -0.11 | -0.1 | -0.11 | -0.12 | -0.1 | -0.1 | -0.15 | -0.11 | -0.1 | -0.11 | -0.21 | -0.19 | -0.2 | -0.18 |
EBITDA | 2.56M | -24.16M | -12.17M | -19.35M | -19.41M | -17.48M | -18.91M | -19.69M | -16.58M | -15.81M | -21.32M | -16.8M | -13.33M | -10.42M | -20.33M | -17.95M | -18.19M | -15.17M |
EBIT | 2.55M | -24.5M | -12.5M | -19.69M | -19.76M | -17.83M | -19.27M | -20.06M | -16.92M | -16.14M | -21.62M | -17.14M | -13.71M | -10.81M | -20.76M | -18.4M | -18.62M | -15.61M |
Depreciation & Amortization | 11K | 333K | 333K | 336K | 356K | 355K | 359K | 369K | 342K | 334K | 307K | 343K | 383K | 394K | 427K | 447K | 436K | 443K |